IPP Bureau
Health Minister Nadda chairs a training program for street food vendors
By IPP Bureau - July 22, 2024
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
DGHS, Health Ministry, along with experts reviews the Chandipura virus and AES cases in states
By IPP Bureau - July 22, 2024
Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
dsm-firmenich to sell MEG-3 fish oil business to KD Pharma Group
By IPP Bureau - July 22, 2024
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Briefs: Zydus Lifesciences and Divi's Laboratories
By IPP Bureau - July 22, 2024
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Rusan Pharma’s API plant in Ankleshwar receives USFDA GMP approval
By IPP Bureau - July 22, 2024
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Budget 2024-25: Industry expects push for reforms, R&D and fiscal incentives
By IPP Bureau - July 22, 2024
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Singhi Advisors facilitates acquisition of 85% stake of GMP Technical Solutions by Japanese Shinryo Corporation
By IPP Bureau - July 22, 2024
This transaction is the third acquisition by three different Japanese players in this segment
New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
By IPP Bureau - July 22, 2024
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Lupin and Huons Sign agreement for commercialization of cyclosporine ophthalmic nanoemulsion in Mexico
By IPP Bureau - July 22, 2024
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome
Lupin’s partner ForDoz receives USFDA approval for doxorubicin hydrochloride liposome injection
By IPP Bureau - July 22, 2024
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Elucid appoints Kelly Huang as CEO
By IPP Bureau - July 22, 2024
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Zydus signs patent licensing agreement with Takeda for 'VaultA’ in India
By IPP Bureau - July 19, 2024
The pooled prevalence of GERD in the Indian population is 15.6 %
Kwality Pharmaceuticals receives DIGIMED approval for generic, injectable and OSD
By IPP Bureau - July 19, 2024
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Vimta Labs posts Q1 FY25consolidated PAT at Rs. 12.28 Cr
By IPP Bureau - July 19, 2024
Vimta Labs has reported total income of Rs. 82.44 crores during the period ended June 30, 2024
